Clinical Advances and New Insights in the Management of Pediatric Atopic Dermatitis is a Satellite Symposium hosted by The Masters of Pediartric Dermatology. In this symposia, expert faculty will lead problem-based learning and inquiry-oriented activities designed to demonstrate practical strategies for the diagnosis and treatment of pediatric AD. Any cases or questions submitted prior to the program will also be shared and addressed.
The symposium is designed to meet the needs of US-based pediatricians, pediatric dermatologists, other practitioners who treat pediatric patients with dermatological conditions.
Upon completion of the educational activity, participants should be able to:
- Identify AD based on the evaluation of clinical characteristics specific to infants, children, and adolescents
- Examine the efficacy and safety of current non-pharmacological and pharmacological treatments for AD patients across the age spectrum
- Define the rationale and mechanism of action for the use of new and emerging agents, including crisaborole, dupilumab, and oral JAK inhibitors in the management of AD
- Develop individualized treatment plans for pediatric patients with AD based on the efficacy and safety of current and new agents, treatment recommendations, and patient and caregiver preferences
CRITERIA FOR SUCCESS
Statements of credit will be awarded based on the participant's attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.livderm.org. You must participate in the entire activity to receive credit. If you have questions about this CME/CE activity, please contact AKH Inc. at email@example.com.
CME/CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba LiVDerm. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded 1.5 Contact Hours.
Activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba LiVDerm.
The Symposium is supported by an independent medical educational grant from Pfizer Inc.
This symposium is neither sponsored nor endorsed by the American Academy of Pediatrics.